Navigation

Duaklir Pressair

  • Generic Name: aclidinium bromide and formoterol fumarate inhalation powder
  • Brand Name: Duaklir Pressair
  • Drug Class: Respiratory Inhalant Combos

side effects drug center duaklir pressair (aclidinium bromide and formoterol fumarate inhalation powder) drug - patient side effects and images

  • Related Drugs
  • Duaklir Pressair Patient Information Including Side Effects

    Brand Names: Duaklir Pressair

    Generic Name: aclidinium and formoterol

    What is aclidinium and formoterol (Duaklir Pressair)?

    Aclidinium and formoterol is a combination medicine used to prevent airflow obstruction and reduce flare-ups in adults with COPD (chronic obstructive pulmonary disease), including bronchitis and emphysema.

    This medicine is for use only in people with COPD and should not be used to treat asthma.

    Aclidinium and formoterol may also be used for purposes not listed in this medication guide.

    What are the possible side effects of aclidinium and formoterol (Duaklir Pressair)?

    Get emergency medical help if you have signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.

    Call your doctor at once if you have:

    • wheezing, choking, or other breathing problems after using this medicine;
    • worsening breathing problems;
    • tremors, nervousness, chest pain, fast or pounding heartbeats;
    • severe headache, pounding in your neck or ears;
    • painful or difficult urination, or urinating more often;
    • blurred vision, tunnel vision, eye pain or redness, or seeing halos around lights;
    • high blood sugar--increased thirst or urination, hunger, dry mouth, fruity breath odor; or
    • low potassium level--leg cramps, constipation, irregular heartbeats, fluttering in your chest, numbness or tingling, muscle weakness or limp feeling.

    Common side effects may include:

    This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

    What is the most important information I should know about aclidinium and formoterol (Duaklir Pressair)?

    Aclidinium and formoterol is for use only in people with chronic obstructive pulmonary disease (COPD) and should not be used to treat asthma.

    You should not use this medicine if you are allergic to aclidinium or formoterol, or if you have a severe allergy to milk proteins.

    Aclidinium and formoterol is not a rescue medicine. It will not work fast enough to treat an bronchospasm attack.

    Seek medical attention if your breathing problems do not improve, or if your symptoms get worse quickly.

    Duaklir Pressair Patient Information including How Should I Take

    What should I discuss with my healthcare provider before using aclidinium and formoterol (Duaklir Pressair)?

    You should not use this medicine if you are allergic to aclidinium or formoterol, or if you have a severe allergy to milk proteins.

    Tell your doctor if you have ever had:

    Tell your doctor if you are pregnant or breastfeeding.

    Aclidinium and formoterol is not approved for use by anyone younger than 18 years old.

    How should I use aclidinium and formoterol (Duaklir Pressair)?

    Follow all directions on your prescription label and read all medication guides. Use the medicine exactly as directed.

    Aclidinium and formoterol is not a rescue medicine for bronchospasm attacks. Use only fast-acting inhalation medicine for an attack. Seek medical attention if your breathing problems get worse quickly, or if you think your medications are not working as well.

    Read and carefully follow any Instructions for Use provided with your medicine. Ask your doctor or pharmacist if you do not understand these instructions.

    Store at room temperature away from moisture, heat, and light. Do not store this medicine on a vibrating surface. Keep the inhaler device in the sealed bag until ready to start using it.

    Throw the inhaler away 2 months after opening the sealed bag, or when the dose indicator shows a zero, or if your inhaler is empty and locks out (whichever comes first).

    You should not stop using aclidinium and formoterol suddenly. Stopping suddenly may make your condition worse.

    Duaklir Pressair Patient Information including If I Miss a Dose

    What happens if I miss a dose (Duaklir Pressair)?

    Skip the missed dose and use your next dose at the regular time. Do not use two doses at one time. Do not use more than 1 inhalation 2 times in a 24-hour period.

    What happens if I overdose (Duaklir Pressair)?

    Seek emergency medical attention or call the Poison Help line at 1-800-222-1222.

    Overdose symptoms may include include blurred vision, dry mouth, nausea, muscle spasms, tremors, headache, and fast or pounding heartbeats.

    What should I avoid while using aclidinium and formoterol (Duaklir Pressair)?

    Do not use a second inhaled bronchodilator that contains formoterol, arformoterol, indacaterol, olodaterol, salmeterol, or formoterol.

    What other drugs will affect aclidinium and formoterol (Duaklir Pressair)?

    Tell your doctor about all your other medicines, especially:

    This list is not complete. Other drugs may affect aclidinium and formoterol, including prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible interactions are listed in this medication guide.

    Where can I get more information (Duaklir Pressair)?

    Your pharmacist can provide more information about aclidinium and formoterol.


    Remember, keep this and all other medicines out of the reach of children, never share your medicines with others, and use this medication only for the indication prescribed.
    Every effort has been made to ensure that the information provided by Cerner Multum, Inc. ('Multum') is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Multum information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Multum does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Multum's drug information does not endorse drugs, diagnose patients or recommend therapy. Multum's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Multum does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    Copyright 1996-2021 Cerner Multum, Inc.